Frank Peters - Publications

Affiliations: 
Industrial and Manufacturing Systems Engineering Iowa State University, Ames, IA, United States 
Area:
Industrial Engineering

75 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2014 Kessel C, Nandakumar KS, Peters FB, Gauba V, Schultz PG, Holmdahl R. A single functional group substitution in c5a breaks B cell and T cell tolerance and protects against experimental arthritis. Arthritis & Rheumatology (Hoboken, N.J.). 66: 610-21. PMID 24574221 DOI: 10.1002/art.38237  0.8
2014 Xiao H, Peters FB, Yang PY, Reed S, Chittuluru JR, Schultz PG. Genetic incorporation of histidine derivatives using an engineered pyrrolysyl-tRNA synthetase. Acs Chemical Biology. 9: 1092-6. PMID 24506189 DOI: 10.1021/cb500032c  0.8
2014 Frank MC, Zhu S, Peters FE. Automated composite fabric layup for wind turbine blades Camx 2014 - Composites and Advanced Materials Expo: Combined Strength. Unsurpassed Innovation. 0.68
2013 Neunzig I, Widjaja M, Peters FT, Maurer HH, Hehn A, Bourgaud F, Bureik M. Coexpression of CPR from various origins enhances biotransformation activity of human CYPs in S. pombe. Applied Biochemistry and Biotechnology. 170: 1751-66. PMID 23737303 DOI: 10.1007/s12010-013-0303-2  0.32
2013 Hardis R, Jessop JLP, Peters FE, Kessler MR. Cure kinetics characterization and monitoring of an epoxy resin using DSC, Raman spectroscopy, and DEA Composites Part a: Applied Science and Manufacturing. 49: 100-108. DOI: 10.1016/j.compositesa.2013.01.021  0.68
2012 Neunzig I, Widjaja M, Drăgan CA, Peters FT, Maurer HH, Bureik M. Engineering of human CYP3A enzymes by combination of activating polymorphic variants. Applied Biochemistry and Biotechnology. 168: 785-96. PMID 22899011 DOI: 10.1007/s12010-012-9819-0  0.32
2012 Carow F, Rieger K, Walter-Sack I, Meyer MR, Peters FT, Maurer HH, Haefeli WE. Objective assessment of nonadherence and unknown co-medication in hospitalized patients. European Journal of Clinical Pharmacology. 68: 1191-9. PMID 22354152 DOI: 10.1007/s00228-012-1229-2  0.32
2012 Wissenbach DK, Meyer MR, Weber AA, Remane D, Ewald AH, Peters FT, Maurer HH. Towards a universal LC-MS screening procedure - can an LIT LC-MS(n) screening approach and reference library be used on a quadrupole-LIT hybrid instrument? Journal of Mass Spectrometry : Jms. 47: 66-71. PMID 22282091 DOI: 10.1002/jms.2027  0.32
2012 Neunzig I, Göhring A, Drăgan CA, Zapp J, Peters FT, Maurer HH, Bureik M. Production and NMR analysis of the human ibuprofen metabolite 3-hydroxyibuprofen. Journal of Biotechnology. 157: 417-20. PMID 22226725 DOI: 10.1016/j.jbiotec.2011.12.016  0.32
2011 Peters FT, Maurer HH, Musshoff F. Forensic toxicology. Analytical and Bioanalytical Chemistry. 400: 7-8. PMID 21331493 DOI: 10.1007/s00216-011-4711-2  0.32
2011 Drăgan CA, Peters FT, Bour P, Schwaninger AE, Schaan SM, Neunzig I, Widjaja M, Zapp J, Kraemer T, Maurer HH, Bureik M. Convenient gram-scale metabolite synthesis by engineered fission yeast strains expressing functional human P450 systems. Applied Biochemistry and Biotechnology. 163: 965-80. PMID 20927605 DOI: 10.1007/s12010-010-9100-3  0.32
2011 Neunzig I, Drăgan CA, Widjaja M, Schwaninger AE, Peters FT, Maurer HH, Bureik M. Whole-cell biotransformation assay for investigation of the human drug metabolizing enzyme CYP3A7. Biochimica Et Biophysica Acta. 1814: 161-7. PMID 20637317 DOI: 10.1016/j.bbapap.2010.07.011  0.32
2010 Zöllner A, Buchheit D, Meyer MR, Maurer HH, Peters FT, Bureik M. Production of human phase 1 and 2 metabolites by whole-cell biotransformation with recombinant microbes. Bioanalysis. 2: 1277-90. PMID 21083240 DOI: 10.4155/bio.10.80  0.32
2010 Remane D, Meyer MR, Peters FT, Wissenbach DK, Maurer HH. Fast and simple procedure for liquid-liquid extraction of 136 analytes from different drug classes for development of a liquid chromatographic-tandem mass spectrometric quantification method in human blood plasma. Analytical and Bioanalytical Chemistry. 397: 2303-14. PMID 20495906 DOI: 10.1007/s00216-010-3820-7  0.32
2010 Groff D, Chen PR, Peters FB, Schultz PG. A genetically encoded epsilon-N-methyl lysine in mammalian cells. Chembiochem : a European Journal of Chemical Biology. 11: 1066-8. PMID 20422671 DOI: 10.1002/cbic.200900690  0.8
2010 Meyer MR, Wilhelm J, Peters FT, Maurer HH. Beta-keto amphetamines: studies on the metabolism of the designer drug mephedrone and toxicological detection of mephedrone, butylone, and methylone in urine using gas chromatography-mass spectrometry. Analytical and Bioanalytical Chemistry. 397: 1225-33. PMID 20333362 DOI: 10.1007/s00216-010-3636-5  0.32
2010 Meyer MR, Peters FT, Maurer HH. Automated mass spectral deconvolution and identification system for GC-MS screening for drugs, poisons, and metabolites in urine. Clinical Chemistry. 56: 575-84. PMID 20185625 DOI: 10.1373/clinchem.2009.135517  0.32
2010 Zöllner A, Parr MK, Drăgan CA, Dräs S, Schlörer N, Peters FT, Maurer HH, Schänzer W, Bureik M. CYP21-catalyzed production of the long-term urinary metandienone metabolite 17beta-hydroxymethyl-17 alpha-methyl-18-norandrosta-1,4,13-trien-3-one: a contribution to the fight against doping. Biological Chemistry. 391: 119-27. PMID 19919183 DOI: 10.1515/BC.2010.002  0.32
2010 Frank MC, Peters FE, Karthikeyan R. Additive/subtractive rapid pattern manufacturing for casting patterns and injection mold tooling 21st Annual International Solid Freeform Fabrication Symposium - An Additive Manufacturing Conference, Sff 2010. 242-255.  0.68
2009 Peters FT, Bureik M, Maurer HH. Biotechnological synthesis of drug metabolites using human cytochrome P450 isozymes heterologously expressed in fission yeast. Bioanalysis. 1: 821-30. PMID 21083140 DOI: 10.4155/bio.09.53  0.32
2009 Fleissner MR, Brustad EM, Kálai T, Altenbach C, Cascio D, Peters FB, Hideg K, Peuker S, Schultz PG, Hubbell WL. Site-directed spin labeling of a genetically encoded unnatural amino acid. Proceedings of the National Academy of Sciences of the United States of America. 106: 21637-42. PMID 19995976 DOI: 10.1073/pnas.0912009106  0.8
2009 Mueller M, Yuan J, Felim A, Neudörffer A, Peters FT, Maurer HH, McCann UD, Largeron M, Ricaurte GA. Further studies on the role of metabolites in (+/-)-3,4-methylenedioxymethamphetamine-induced serotonergic neurotoxicity. Drug Metabolism and Disposition: the Biological Fate of Chemicals. 37: 2079-86. PMID 19628751 DOI: 10.1124/dmd.109.028340  0.32
2009 Meyer MR, Peters FT, Maurer HH. Investigations on the human hepatic cytochrome P450 isozymes involved in the metabolism of 3,4-methylenedioxy-amphetamine (MDA) and benzodioxolyl-butanamine (BDB) enantiomers. Toxicology Letters. 190: 54-60. PMID 19576971 DOI: 10.1016/j.toxlet.2009.06.866  0.32
2009 Peters FT, Dragan CA, Kauffels A, Schwaninger AE, Zapp J, Bureik M, Maurer HH. Biotechnological synthesis of the designer drug metabolite 4'-hydroxymethyl-alpha-pyrrolidinohexanophenone in fission yeast heterologously expressing human cytochrome P450 2D6--a versatile alternative to multistep chemical synthesis. Journal of Analytical Toxicology. 33: 190-7. PMID 19470220  0.32
2009 Meyer MR, Peters FT, Maurer HH. Stereoselective differences in the cytochrome P450-dependent dealkylation and demethylenation of N-methyl-benzodioxolyl-butanamine (MBDB, Eden) enantiomers. Biochemical Pharmacology. 77: 1725-34. PMID 19428327 DOI: 10.1016/j.bcp.2009.03.001  0.32
2009 Mueller M, Kolbrich EA, Peters FT, Maurer HH, McCann UD, Huestis MA, Ricaurte GA. Direct comparison of (+/-) 3,4-methylenedioxymethamphetamine ("ecstasy") disposition and metabolism in squirrel monkeys and humans. Therapeutic Drug Monitoring. 31: 367-73. PMID 19417716 DOI: 10.1097/FTD.0b013e3181a4f6c2  0.32
2009 Meyer MR, Peters FT, Maurer HH. The role of human hepatic cytochrome P450 isozymes in the metabolism of racemic 3,4-methylenedioxyethylamphetamine and its single enantiomers. Drug Metabolism and Disposition: the Biological Fate of Chemicals. 37: 1152-6. PMID 19299523 DOI: 10.1124/dmd.108.026203  0.32
2009 Peters FB, Brock A, Wang J, Schultz PG. Photocleavage of the polypeptide backbone by 2-nitrophenylalanine. Chemistry & Biology. 16: 148-52. PMID 19246005 DOI: 10.1016/j.chembiol.2009.01.013  0.8
2009 Sauer C, Peters FT, Haas C, Meyer MR, Fritschi G, Maurer HH. New designer drug alpha-pyrrolidinovalerophenone (PVP): studies on its metabolism and toxicological detection in rat urine using gas chromatographic/mass spectrometric techniques. Journal of Mass Spectrometry : Jms. 44: 952-64. PMID 19241365 DOI: 10.1002/jms.1571  0.32
2009 Mueller M, Kolbrich-Spargo EA, Peters FT, Huestis MA, Ricaurte GA, Maurer HH. Hydrolysis of 3,4-methylenedioxymethamphetamine (MDMA) metabolite conjugates in human, squirrel monkey, and rat plasma. Analytical and Bioanalytical Chemistry. 393: 1607-17. PMID 19183967 DOI: 10.1007/s00216-009-2607-1  0.32
2009 Peters FT, Dragan CA, Schwaninger AE, Sauer C, Zapp J, Bureik M, Maurer HH. Use of fission yeast heterologously expressing human cytochrome P450 2B6 in biotechnological synthesis of the designer drug metabolite N-(1-phenylcyclohexyl)-2-hydroxyethanamine. Forensic Science International. 184: 69-73. PMID 19135815 DOI: 10.1016/j.forsciint.2008.12.001  0.32
2009 Mueller M, Peters FT, Huestis MA, Ricaurte GA, Maurer HH. Simultaneous liquid chromatographic-electrospray ionization mass spectrometric quantification of 3,4-methylenedioxymethamphetamine (MDMA, Ecstasy) and its metabolites 3,4-dihydroxymethamphetamine, 4-hydroxy-3-methoxymethamphetamine and 3,4-methylenedioxyamphetamine in squirrel monkey and human plasma after acidic conjugate cleavage. Forensic Science International. 184: 64-8. PMID 19131196 DOI: 10.1016/j.forsciint.2008.12.002  0.32
2009 Zöllner A, Dragan CA, Pistorius D, Müller R, Bode HB, Peters FT, Maurer HH, Bureik M. Human CYP4Z1 catalyzes the in-chain hydroxylation of lauric acid and myristic acid. Biological Chemistry. 390: 313-7. PMID 19090726 DOI: 10.1515/BC.2009.030  0.32
2009 Sauer C, Peters FT, Schwaninger AE, Meyer MR, Maurer HH. Investigations on the cytochrome P450 (CYP) isoenzymes involved in the metabolism of the designer drugs N-(1-phenyl cyclohexyl)-2-ethoxyethanamine and N-(1-phenylcyclohexyl)-2-methoxyethanamine. Biochemical Pharmacology. 77: 444-50. PMID 19022226 DOI: 10.1016/j.bcp.2008.10.024  0.32
2009 Frank MC, Peters FE, Luo X, Meng F, Petrzelka J. A hybrid rapid pattern manufacturing system for sand castings 20th Annual International Solid Freeform Fabrication Symposium, Sff 2009. 35-46.  0.68
2008 Sauer C, Peters FT, Staack RF, Fritschi G, Maurer HH. Metabolism and toxicological detection of the designer drug N-(1-phenylcyclohexyl)-3-methoxypropanamine (PCMPA) in rat urine using gas chromatography-mass spectrometry. Forensic Science International. 181: 47-51. PMID 18922655 DOI: 10.1016/j.forsciint.2008.09.001  0.32
2008 Mueller M, Peters FT, Ricaurte GA, Maurer HH. Liquid chromatographic-electrospray ionization mass spectrometric assay for simultaneous determination of 3,4-methylenedioxymethamphetamine and its metabolites 3,4-methylenedioxyamphetamine, 3,4-dihydroxymethamphetamine, and 4-hydroxy-3-methoxymethamphetamine in rat brain. Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences. 874: 119-24. PMID 18829400 DOI: 10.1016/j.jchromb.2008.09.009  0.32
2008 Sauer C, Peters FT, Schwaninger AE, Meyer MR, Maurer HH. Identification of cytochrome P450 enzymes involved in the metabolism of the designer drugs N-(1-phenylcyclohexyl)-3-ethoxypropanamine and N-(1-phenylcyclohexyl)-3-methoxypropanamine. Chemical Research in Toxicology. 21: 1949-55. PMID 18778087 DOI: 10.1021/tx8001302  0.32
2008 Meyer MR, Peters FT, Maurer HH. The role of human hepatic cytochrome P450 isozymes in the metabolism of racemic 3,4-methylenedioxy-methamphetamine and its enantiomers. Drug Metabolism and Disposition: the Biological Fate of Chemicals. 36: 2345-54. PMID 18725511 DOI: 10.1124/dmd.108.021543  0.32
2008 Mueller M, Peters FT, Maurer HH, McCann UD, Ricaurte GA. Nonlinear pharmacokinetics of (+/-)3,4-methylenedioxymethamphetamine (MDMA, "Ecstasy") and its major metabolites in squirrel monkeys at plasma concentrations of MDMA that develop after typical psychoactive doses. The Journal of Pharmacology and Experimental Therapeutics. 327: 38-44. PMID 18591215 DOI: 10.1124/jpet.108.141366  0.32
2008 Sauer C, Peters FT, Staack RF, Fritschi G, Maurer HH. Metabolism and toxicological detection of a new designer drug, N-(1-phenylcyclohexyl)propanamine, in rat urine using gas chromatography-mass spectrometry. Journal of Chromatography. A. 1186: 380-90. PMID 18035363 DOI: 10.1016/j.chroma.2007.11.002  0.32
2008 Sauer C, Peters FT, Staack RF, Fritschi G, Maurer HH. New designer drugs N-(1-phenylcyclohexyl)-2-ethoxyethanamine (PCEEA) and N-(1-phenylcyclohexyl)-2-methoxyethanamine (PCMEA): Studies on their metabolism and toxicological detection in rat urine using gas chromatographic/mass spectrometric techniques. Journal of Mass Spectrometry : Jms. 43: 305-16. PMID 17968862 DOI: 10.1002/jms.1312  0.32
2008 Peters FT, Meyer MR, Theobald DS, Maurer HH. Identification of cytochrome P450 enzymes involved in the metabolism of the new designer drug 4'-methyl-alpha-pyrrolidinobutyrophenone. Drug Metabolism and Disposition: the Biological Fate of Chemicals. 36: 163-8. PMID 17962373 DOI: 10.1124/dmd.107.017293  0.32
2007 Mueller M, Peters FT, Ricaurte GA, Maurer HH. Validated liquid chromatographic-electrospray ionization mass spectrometric assay for simultaneous determination of 3,4-methylenedioxymethamphetamine and its metabolites 3,4-methylenedioxyamphetamine, 3,4-dihydroxymethamphetamine, and 4-hydroxy-3-methoxymethamphetamine in squirrel monkey plasma. Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences. 855: 262-70. PMID 17646137 DOI: 10.1016/j.jchromb.2007.06.034  0.32
2007 Peters FT, Dragan CA, Wilde DR, Meyer MR, Zapp J, Bureik M, Maurer HH. Biotechnological synthesis of drug metabolites using human cytochrome P450 2D6 heterologously expressed in fission yeast exemplified for the designer drug metabolite 4'-hydroxymethyl-alpha-pyrrolidinobutyrophenone. Biochemical Pharmacology. 74: 511-20. PMID 17572388 DOI: 10.1016/j.bcp.2007.05.010  0.32
2007 Peters FT, Maurer HH. Systematic comparison of bias and precision data obtained with multiple-point and one-point calibration in six validated multianalyte assays for quantification of drugs in human plasma. Analytical Chemistry. 79: 4967-76. PMID 17518444 DOI: 10.1021/ac070054s  0.32
2007 Peters FT, Samyn N, Kraemer T, Riedel WJ, Maurer HH. Negative-ion chemical ionization gas chromatography-mass spectrometry assay for enantioselective measurement of amphetamines in oral fluid: application to a controlled study with MDMA and driving under the influence cases. Clinical Chemistry. 53: 702-10. PMID 17332148 DOI: 10.1373/clinchem.2006.081547  0.32
2007 Beyer J, Peters FT, Kraemer T, Maurer HH. Detection and validated quantification of toxic alkaloids in human blood plasma--comparison of LC-APCI-MS with LC-ESI-MS/MS. Journal of Mass Spectrometry : Jms. 42: 621-33. PMID 17323418 DOI: 10.1002/jms.1191  0.32
2007 von Mach MA, Weber C, Meyer MR, Weilemann LS, Maurer HH, Peters FT. Comparison of urinary on-site immunoassay screening and gas chromatography-mass spectrometry results of 111 patients with suspected poisoning presenting at an emergency department. Therapeutic Drug Monitoring. 29: 27-39. PMID 17304147 DOI: 10.1097/FTD.0b013e31802bb2aa  0.32
2007 Beyer J, Peters FT, Kraemer T, Maurer HH. Detection and validated quantification of nine herbal phenalkylamines and methcathinone in human blood plasma by LC-MS/MS with electrospray ionization. Journal of Mass Spectrometry : Jms. 42: 150-60. PMID 17154352 DOI: 10.1002/jms.1132  0.32
2006 Sauer C, Peters FT, Staack RF, Fritschi G, Maurer HH. New designer drug N-(1-phenylcyclohexyl)-3-ethoxypropanamine (PCEPA): studies on its metabolism and toxicological detection in rat urine using gas chromatographic/mass spectrometric techniques. Journal of Mass Spectrometry : Jms. 41: 1014-29. PMID 16817170 DOI: 10.1002/jms.1058  0.32
2005 Maurer HH, Peters FT. Toward high-throughput drug screening using mass spectrometry. Therapeutic Drug Monitoring. 27: 686-8. PMID 16404794  0.32
2005 Peters FT, Samyn N, Lamers CT, Riedel WJ, Kraemer T, de Boeck G, Maurer HH. Drug testing in blood: validated negative-ion chemical ionization gas chromatographic-mass spectrometric assay for enantioselective measurement of the designer drugs MDEA, MDMA, and MDA and its application to samples from a controlled study with MDMA. Clinical Chemistry. 51: 1811-22. PMID 16099938 DOI: 10.1373/clinchem.2005.052746  0.32
2005 Peters FT, Meyer MR, Fritschi G, Maurer HH. Studies on the metabolism and toxicological detection of the new designer drug 4'-methyl-alpha-pyrrolidinobutyrophenone (MPBP) in rat urine using gas chromatography-mass spectrometry. Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences. 824: 81-91. PMID 16046201 DOI: 10.1016/j.jchromb.2005.07.003  0.32
2005 Beyer J, Bierl A, Peters FT, Maurer HH. Screening procedure for detection of diuretics and uricosurics and/or their metabolites in human urine using gas chromatography-mass spectrometry after extractive methylation. Therapeutic Drug Monitoring. 27: 509-20. PMID 16044110  0.32
2005 Ewald AH, Peters FT, Weise M, Maurer HH. Studies on the metabolism and toxicological detection of the designer drug 4-methylthioamphetamine (4-MTA) in human urine using gas chromatography-mass spectrometry. Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences. 824: 123-31. PMID 16027051 DOI: 10.1016/j.jchromb.2005.07.007  0.32
2005 Peters FT, Jung J, Kraemer T, Maurer HH. Fast, simple, and validated gas chromatographic-mass spectrometric assay for quantification of drugs relevant to diagnosis of brain death in human blood plasma samples. Therapeutic Drug Monitoring. 27: 334-44. PMID 15905804  0.32
2005 Habrdova V, Peters FT, Theobald DS, Maurer HH. Screening for and validated quantification of phenethylamine-type designer drugs and mescaline in human blood plasma by gas chromatography/mass spectrometry. Journal of Mass Spectrometry : Jms. 40: 785-95. PMID 15827969 DOI: 10.1002/jms.853  0.32
2005 Beyer J, Peters FT, Maurer HH. Screening procedure for detection of stimulant laxatives and/or their metabolites in human urine using gas chromatography-mass spectrometry after enzymatic cleavage of conjugates and extractive methylation. Therapeutic Drug Monitoring. 27: 151-7. PMID 15795644  0.32
2004 Maurer HH, Tenberken O, Kratzsch C, Weber AA, Peters FT. Screening for library-assisted identification and fully validated quantification of 22 beta-blockers in blood plasma by liquid chromatography-mass spectrometry with atmospheric pressure chemical ionization. Journal of Chromatography. A. 1058: 169-81. PMID 15595665  0.32
2004 Kratzsch C, Tenberken O, Peters FT, Weber AA, Kraemer T, Maurer HH. Screening, library-assisted identification and validated quantification of 23 benzodiazepines, flumazenil, zaleplone, zolpidem and zopiclone in plasma by liquid chromatography/mass spectrometry with atmospheric pressure chemical ionization. Journal of Mass Spectrometry : Jms. 39: 856-72. PMID 15329838 DOI: 10.1002/jms.599  0.32
2004 Kraemer T, Pflugmann T, Bossmann M, Kneller NM, Peters FT, Paul LD, Springer D, Staack RF, Maurer HH. Fenproporex N-dealkylation to amphetamine--enantioselective in vitro studies in human liver microsomes as well as enantioselective in vivo studies in Wistar and Dark Agouti rats. Biochemical Pharmacology. 68: 947-57. PMID 15294457 DOI: 10.1016/j.bcp.2004.05.009  0.32
2004 Rieger K, Scholer A, Arnet I, Peters FT, Maurer HH, Walter-Sack I, Haefeli WE, Martin-Facklam M. High prevalence of unknown co-medication in hospitalised patients European Journal of Clinical Pharmacology. 60: 363-368. PMID 15197522  0.32
2004 Ryan SM, Jackman JK, Peters FE, Ólafsson S, Huba ME. The engineering learning portal for problem solving: Experience in a large engineering economy class Engineering Economist. 49: 1-19. DOI: 10.1080/00137910490432575  0.68
2004 Jackman JK, Olafsson S, Peters FE, Ryan SM, Saunders K. Integrated curriculum to improve engineering problem solving Iie Annual Conference and Exhibition 2004. 249-254.  0.68
2003 Peters FT, Schaefer S, Staack RF, Kraemer T, Maurer HH. Screening for and validated quantification of amphetamines and of amphetamine- and piperazine-derived designer drugs in human blood plasma by gas chromatography/mass spectrometry. Journal of Mass Spectrometry : Jms. 38: 659-76. PMID 12827635 DOI: 10.1002/jms.483  0.32
2003 Springer D, Peters FT, Fritschi G, Maurer HH. New designer drug 4'-methyl-alpha-pyrrolidinohexanophenone: studies on its metabolism and toxicological detection in urine using gas chromatography-mass spectrometry. Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences. 789: 79-91. PMID 12726846  0.32
2003 Kraemer T, Roditis SK, Peters FT, Maurer HH. Amphetamine concentrations in human urine following single-dose administration of the calcium antagonist prenylamine-studies using fluorescence polarization immunoassay (FPIA) and GC-MS. Journal of Analytical Toxicology. 27: 68-73. PMID 12669999  0.32
2003 Kratzsch C, Peters FT, Kraemer T, Weber AA, Maurer HH. Screening, library-assisted identification and validated quantification of fifteen neuroleptics and three of their metabolites in plasma by liquid chromatography/mass spectrometry with atmospheric pressure chemical ionization. Journal of Mass Spectrometry : Jms. 38: 283-95. PMID 12644990 DOI: 10.1002/jms.440  0.32
2002 Peters FT, Kraemer T, Maurer HH. Drug testing in blood: validated negative-ion chemical ionization gas chromatographic-mass spectrometric assay for determination of amphetamine and methamphetamine enantiomers and its application to toxicology cases. Clinical Chemistry. 48: 1472-85. PMID 12194924  0.32
2002 Maurer HH, Kratzsch C, Weber AA, Peters FT, Kraemer T. Validated assay for quantification of oxcarbazepine and its active dihydro metabolite 10-hydroxycarbazepine in plasma by atmospheric pressure chemical ionization liquid chromatography/mass spectrometry. Journal of Mass Spectrometry : Jms. 37: 687-92. PMID 12125001 DOI: 10.1002/jms.325  0.32
2002 Maurer HH, Kratzsch C, Kraemer T, Peters FT, Weber AA. Screening, library-assisted identification and validated quantification of oral antidiabetics of the sulfonylurea-type in plasma by atmospheric pressure chemical ionization liquid chromatography-mass spectrometry. Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences. 773: 63-73. PMID 12015271  0.32
2002 Springer D, Peters FT, Fritschi G, Maurer HH. Studies on the metabolism and toxicological detection of the new designer drug 4'-methyl-alpha-pyrrolidinopropiophenone in urine using gas chromatography-mass spectrometry. Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences. 773: 25-33. PMID 12015267  0.32
2002 Maurer HH, Kraemer T, Kratzsch C, Peters FT, Weber AA. Negative ion chemical ionization gas chromatography-mass spectrometry and atmospheric pressure chemical ionization liquid chromatography-mass spectrometry of low-dosed and/or polar drugs in plasma. Therapeutic Drug Monitoring. 24: 117-24. PMID 11805732  0.32
1998 Salisbury EJ, Peters FE. The impact of surface errors on fixtured workpiece location and orientation Technical Paper - Society of Manufacturing Engineers. Ms. 98.  0.68
Show low-probability matches.